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Background: Identifying the unique and shared premorbid indicators of risk for the schizophrenia spectrum
disorders (SSD) and affective psychoses (AP) may refine aetiological hypotheses and inform the delivery of universal
versus targeted preventive interventions. This systematic review synthesises the available evidence concerning
developmental risk factors and antecedents of SSD and AP to identify those with the most robust support, and to
highlight remaining evidence gaps.
Methods: A systematic search of prospective birth, population, high-risk, and case-control cohorts was conducted
in Medline and supplemented by hand searching, incorporating published studies in English with full text available.
Inclusion/exclusion decisions and data extraction were completed in duplicate. Exposures included three categories
of risk factors and four categories of antecedents, with case and comparison groups defined by adult psychiatric
diagnosis. Effect sizes and prevalence rates were extracted, where available, and the strength of evidence
synthesised and evaluated qualitatively across the study designs.
Results: Of 1775 studies identified by the search, 127 provided data to the review. Individuals who develop SSD
experience a diversity of subtle premorbid developmental deficits and risk exposures, spanning the prenatal period
through early adolescence. Those of greatest magnitude (or observed most consistently) included obstetric
complications, maternal illness during pregnancy (especially infections), other maternal physical factors, negative
family emotional environment, psychopathology and psychotic symptoms, and cognitive and motor dysfunctions.
Relatively less evidence has accumulated to implicate this diversity of exposures in AP, and many yet remain
unexamined, with the most consistent or strongest evidence to date being for obstetric complications,
psychopathology, cognitive indicators and motor dysfunction. Among the few investigations affording direct
comparison between SSD and AP, larger effect sizes and a greater number of significant associations are commonly
reported for SSD relative to AP.
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Conclusions: Shared risk factors for SSD and AP may include obstetric complications, childhood psychopathology,
cognitive markers and motor dysfunction, but the capacity to distinguish common versus distinct risk factors/antecedents
for SSD and AP is limited by the scant availability of prospective data for AP, and inconsistency in replication. Further
studies considering both diagnoses concurrently are needed. Nonetheless, the prevalence of the risk factors/antecedents
observed in cases and controls helps demarcate potential targets for preventative interventions for these disorders.Background
Accumulating evidence has identified childhood and ado-
lescent developmental risk factors and antecedents for
schizophrenia spectrum disorders (SSD) and affective
psychoses (AP), but the extent to which these factors may
be common or unique to each disorder remains unclear. In
the context of recent evidence of shared genetic vulner-
ability for schizophrenia and bipolar disorder [1–5],
and potential similarities in their neuropathology [6, 7],
distinguishing shared versus unique features of the devel-
opmental pathways to these disorders is important for de-
termining their pathogenesis and the development of
preventative interventions. Antecedents of a disorder may
be expressed as premorbid deviations in brain develop-
ment, evident in subtle deficits in functioning and delayed
developmental milestones that likely reflect early expres-
sion of pathology, while risk factors include various social
or physical environmental exposures that may represent
modifiable targets for prevention [8, 9]. The term ‘risk fac-
tors’ is applied here to those indicators that may constitute
relatively passive markers of increased risk, whereas ‘ante-
cedents’ is used to demarcate factors that are putatively in-
dicative of active risk-modifying mechanisms or processes
through which the illness outcome may arise. Nonethe-
less, this distinction between risk factors and antecedents
remains arbitrary with respect to our understanding of the
developmental pathway to SSD and AP; this review fo-
cuses on summarising the evidence for shared and distinct
developmental profiles for these disorders, but does not
address the distinction between risk-factors and anteced-
ents directly.
Previous evidence suggests that some risk factors and
antecedents may represent generalised precursors to a
range of disorders, while others may be specific to SSD
or to AP. For instance, childhood emotional and inter-
personal deviance is associated with both SSD and AP
[9, 10], whereas premorbid impairment in motor,
language, and cognitive functioning [11, 12], obstetric
complications [13, 14] and various environmental expo-
sures [8, 15], have been more commonly associated with
SSD than AP. However, prior reviews have focused on
synthesising evidence only for a single diagnostic outcome
rather than comparing the disorders directly. Longitudinal
studies prospectively assessing risk factors and antecedents
for SSD and AP during childhood or early adolescenceprovide a particularly sound basis for delineating the
developmental trajectories of each disorder, avoiding
potential recall bias inherent in retrospective reporting
[16]. These studies predominantly use population-based
(including birth) cohorts or nested case-control designs.
Whilst the latter allow for greater control over potential
confounders, the large non-selected samples utilised in
population-based cohorts provide greater precision in
effect size estimates [17] and minimise selection bias [18].
Routinely-collected administrative datasets are increas-
ingly used in large-scale population studies as they provide
access to a wealth of prospectively gathered developmen-
tal data for low-prevalence psychiatric outcomes such as
SSD and AP, particularly in relation to demographic and
perinatal factors [19–21]. Other prospective investigations
have followed the development of children with a family
history of SSD or AP, typically the offspring of affected
mothers, using a “high-risk” design that enriches the study
sample with individuals who later develop the disorder in
question (e.g. [22–24]). High-risk studies offer the poten-
tial to explore gene-environment interactions; however, as
only a minority of people with SSD or AP have a first- or
second-degree relative with these disorders [25, 26], find-
ings from these studies may not generalise to the majority
without a family history.
The objective of this systematic review was to summarise
the available evidence on risk factors and antecedents of
SSD and AP from cohorts providing prospectively gathered
data, to identify common and distinct factors characterising
the risk profiles for SSD and AP, ascertain the prevalence of
these factors in both cases and comparison groups, and
ultimately highlight potential targets for universal and tar-
geted preventative interventions. Retrospectively gathered
data was not included in order to reduce the risk of report-
ing bias that is inherent in the use of such data. Risk factors
were reviewed within three main categories: (i) conception,
pregnancy, and birth risk factors, (ii) demographic and fa-
milial risk factors, and (iii) childhood and adolescent risk
factors. Antecedents were considered within four categor-
ies: (i) social, emotional, and behavioural functioning, and
psychosis symptoms, (ii) cognitive functioning, (iii) lan-
guage functioning, and (iv) motor functioning and devel-
opmental motor milestones. For each category, we firstly
present the effect sizes specific to each for these groups of
disorders, to identify factors supported by the most robust
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evidence was precluded because too few factors had been
measured consistently across studies. Secondly, we high-
light where potential risk factors or antecedents have not
yet been examined or are available for just one group of
disorders, so that future research can be directed to fill
these gaps in knowledge.
Methods
This systematic review was designed and reported
according to the guidance provided by the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA [27]; see Additional file 1).
Search strategy
Search terms (exp schizophrenia, schizophreni*, exp bi-
polar disorder, bipolar.tw, exp affective psychosis, birth
cohort, population cohort, longitudinal study, prospect-
ive study, high-risk; limited to full-text, English language
publications) were applied to Medline in July 2014, and
supplemented by extensive hand searching of citations
and reference lists to identify additional studies. (‘exp’ and
‘.tw’ are Medline terms respectively signifying ‘explode’
and ‘text word’).
Study selection criteria
Studies were included if they satisfied the following
criteria: (i) population or birth cohort studies, or case-
control studies (including high-risk studies) where risk/
antecedent measures were collected prospectively, (ii) mea-
sured antecedents and risk factors at mean age ≤15 years
(in attempt to distinguish premorbid indicators from po-
tential early symptoms/signs of illness [28]), (iii) diagnoses
of SSD or AP obtained through standardised structured
interview, hospital records or administrative registers, (iv)
written in English, and (v) full text of the manuscript avail-
able. Studies excluded were those that relied on retrospect-
ive reports of exposures, did not provide a standardised or
administrative psychiatric diagnosis, or examined indirect
exposures (i.e., assessed only at the population rather than
individual level). The decision to include or exclude studies
was conducted in duplicate by two of the authors (LL and
SLM).
Case and comparison groups
Case and comparison groups were defined by adult psy-
chiatric diagnosis. Case groups comprised individuals
diagnosed with SSDs (namely, schizophrenia, schizoaffec-
tive disorder, schizophreniform disorder, and other schizo-
phrenia spectrum disorders) or APs (namely, bipolar
disorder, mania, major depressive disorder with psychosis,
and other affective psychoses). These groupings reflected
the typical treatment of diagnoses within the primary
studies included in the review – for example, a majority ofstudies included schizoaffective disorder as a SSD rather
than AP. Where the primary study provided insufficient
diagnostic information to be able to assign it to the SSD
or AP outcome (e.g., ‘first-episode psychosis’), the study
was excluded from the review. Three types of comparison
groups were considered, as shown in the supplementary
tables: (i) population controls (i.e., all those in the sample
who did not have a SSD or AP), (ii) other (non-SSD or
non-AP) psychiatric diagnoses only, and (iii) healthy con-
trols only.
Data extraction and analysis
Data extraction was conducted in duplicate by two of
the authors (LL and SLM). Risk factors were reviewed
within three main categories: (i) conception, pregnancy,
and birth risk factors, (ii) demographic and familial risk
factors, and (iii) childhood and adolescent risk factors.
Antecedents were considered within four categories: (i)
social, emotional, and behavioural functioning, and psych-
osis symptoms, (ii) cognitive functioning, (iii) language
functioning, and (iv) motor functioning and developmental
motor milestones. Each antecedent was further delineated
by the age at assessment in order to characterise the devel-
opmental timing at which antecedents were apparent. Age
was grouped according to those most commonly reported
across studies, namely: (i) early childhood (0–5 years), (ii)
middle childhood (6–12 years), and (iii) early adolescence
(13–15 years). Where studies reported data that overlapped
these age groups, the findings were allocated to the age
bracket that incorporated the greater number of years (e.g.,
data reported in [29], spanning ages 3 to 9 years, were allo-
cated to middle rather than early childhood).
Where available, adjusted effect sizes (odds ratios [ORs],
risk ratios [RRs], hazard ratios [HRs], or incidence rate
ratios [IRRs]) are reported as provided in the individual
studies. For studies where adjusted effect sizes were not re-
ported by the original manuscripts, estimated (unadjusted)
ORs (calculated using proportions extracted from the
primary studies) are presented. Where those proportions
were not reported, we instead estimated the ORs from
standardised mean differences (SMDs), F- or t-statistics, or
regression coefficients (as per the Practical Meta-Analysis
Effect Size Calculator: http://www.campbellcollaboratio-
n.org/resources/effect_size_input.php). As the majority of
outcome data were dichotomous in nature, these effect
sizes were estimated using ORs. For those studies that pro-
vided data permitting extraction of the prevalence rates of
each risk factor/antecedent for each diagnostic group, these
are also incorporated in the tables, indicating how com-
mon each risk factor/antecedent is in cases and controls.
To synthesise and evaluate qualitatively the strength of
evidence available, and for ease of interpretation, the evi-
dence from each study for risk factors and antecedents is
summarized in Tables 1 and 2 using symbols that code: (i)
Table 1 Evidence summary (by estimated magnitude of effect) of factors that increase risk of SSD and AP
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Table 2 Evidence summary (by estimated magnitude of effect) of childhood antecedents that increase risk of SSD and AP
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cohort, or other non-high-risk case-control control); (ii) the
largest reported or estimated significant effect sizedetermined for each factor/antecedent, with grouping
guided by the criteria of Rosenthal [30] and GRADEPro
2008 [31] and designated as large (OR/HR/RR/IRR: >5
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[or 0.2–0.5]), small (OR/HR/RR/IRR: <2 [or >0.5]), or no
statistically significant effect; and (iii) whether the effect is
adjusted or unadjusted. Where both adjusted and un-
adjusted effects sizes were reported, only the adjusted data
are presented in the Tables.
To reduce the risk of reporting bias, only data from
prospective studies were synthesised and evaluated.
While a formal quality assessment of the evidence from
individual studies (including risk of bias) was beyond the
scope of this review, the population/birth cohort studies
typically provided greater precision in the effect esti-
mates and less selection bias relative to the high-risk
and case-control investigations. Thus, for each risk fac-
tor or antecedent category considered, we indicate in the
text the number of cohorts of different design providing
data, then present the evidence derived from cohortsFig. 1 PRISMA diagram summarising the flow of information through the pproviding data for both SSD and AP (permitting direct
comparison), and additional evidence available from co-
horts reporting solely on SSD or AP outcomes.
Results
Figure 1 presents a PRISMA flow chart summary of the
search and review process, including reasons for study
exclusion. The Medline search identified 1794 potential
studies, with a further 75 studies identified through hand-
searching. A total of 127 studies met inclusion criteria.
Tables 1 and 2 present the evidence for risk factors
and antecedents, respectively; and, for each risk factor/
antecedent category, the design of the cohorts and a syn-
thesis of the findings reported by each study. Additional
file 2: Tables S1-S4 provide detailed information from
each study (reported by study citation) including sample
size, diagnosis, age at outcome assessment (diagnosis),hases of systematic review
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factor/antecedent measure, prevalence rates for the out-
come, and effect sizes for cases relative to comparison
group. Additional file 3: Table S5 provides further details
regarding the study cohort and design for each citation,
measurements used for diagnostic outcome and expos-
ure variables and, where applicable, any confounding
variables adjusted in the analyses.
Conception, pregnancy, and birth risk factors (Table 1;
Additional file 2: Table S1)
Maternal psychological factors during pregnancy
Limited data regarding the effects of maternal psycho-
logical factors during pregnancy on risk for later SSD
in the offspring were available from two birth cohorts
[32, 33], one population cohort [34], and one high-risk
cohort [35]; no comparable studies were available for AP.
Maternal psychological factors did not confer a significant
increase in risk for SSD, with the exception of a medium-
sized effect for depressed mood during pregnancy, only
when either parent had a psychotic disorder [33]. Further
research on the impact of maternal psychological factors
during pregnancy is needed for both SSD and AP, al-
though their influence may be limited.
Maternal illness during pregnancy
Evidence for the effects of maternal illness during preg-
nancy on SSD was available from three birth cohorts
[36–39], two population cohorts [40, 41], two high-risk
cohorts [42, 43], and six case-control cohorts [44–53].
Two of the latter [48, 50] also provided comparative data
on AP, as did a Bain et al. ([54]; a companion study to
the SSD investigation by Kendall et al. [52]). Another
two case-control cohorts reported only on AP [55, 56].
The three case-control cohorts providing data on both
SSD and AP showed no significant increase in risk for
either diagnosis from hypertension and diabetes in preg-
nancy [50], or from pre-existing maternal physical illness
[52, 54]. There was a significant effect for maternal in-
fection and hypertension on SSD in one of the high-risk
cohorts [42]. Similarly, herpes simplex virus infection
(HSV-2) conferred a significantly increased risk for SSD,
but not AP, in one of the case-control studies [48].
Among the studies examining only SSD, a significantly
increased risk was identified for in-utero exposure to
infectious diseases, including prenatal exposure to ma-
ternal genital and reproductive infections around the
time of conception [36], gonococcal infection [39], HSV-
2 [53], (but see [47]), respiratory infection in the second
trimester [37], prenatal upper respiratory bacterial infec-
tion (not pneumonia [39]), influenza in the first trimes-
ter or first half of pregnancy [44], any treated maternal
infection [41], and any physical illness during pregnancy
[43] (but see [40, 42, 51, 52]), as well as any bacterialinfection in the first trimester [39]. Compared with con-
trols, increased risk of SSD among offspring was indexed
also by markers of inflammation, including elevated mater-
nal interleukin-8 levels [45] and C-reactive protein [49], but
not maternal antibodies to toxoplasmosis [46]. For AP, two
studies from a single case-control cohort provided evidence
that maternal influenza was associated with an increased
risk for AP [55, 56]. Thus, considerable evidence, mostly of
small- or medium-sized effect (two cohorts reported large
effects [36, 43]), suggests increased risk of SSD from
prenatal exposure to maternal illness, especially infectious
diseases. In contrast, the relative lack of studies examining
AP precludes definitive conclusions, with current findings
limited to the large effect for maternal influenza in two
studies based on a single case-control cohort [49, 56].
Previous pregnancies
Two birth cohorts [57, 58], a population cohort [59], a
high-risk cohort [42], and two case-control cohorts
[49, 50] investigated the effects of previous pregnancy
history on SSD or AP, with three studies reporting
data for both outcomes [50, 58, 59]. Nosarti et al. [59]
indicated an increased risk of SSD in offspring of
mothers with parity of 1 and of ≥4, but a decreased
risk in offspring of mothers with parity of 2–3 (but see
[49] for lack of significant finding for parity ≥2); con-
versely, a reduced risk for AP was observed among off-
spring of mothers with parity of 2–3, and of ≥4 (but not for
parity of 1). Sacker et al. [58] reported increased risk only
for SSD in offspring of mothers with two prior pregnancies.
No significant effects for grand multiparity (6+), or for prior
miscarriages and abortions were observed for SSD, factors
that remain untested in AP [42, 57]. Where observed, sig-
nificant effect sizes were small or medium in magnitude.
Other physical factors
Data on the risk of SSD in offspring that is conferred by
maternal physical factors during pregnancy (other than
those relating to illness or parity) were reported in studies
drawn from three birth cohorts [45, 60–64], two high-risk
cohorts [65, 66], and three case-control cohorts [50, 51, 67].
Hultman et al. [50] examined both SSD and AP outcomes,
while another case-control cohort investigated the AP
outcome only [67]. In the only cohort examining both
outcomes, an increased risk for both SSD and AP was
conferred by winter birth [50], although data from two
smaller high-risk cohorts indicated no effect of winter
birth on SSD [65, 66]. Compared with controls, increased
risk of SSD was reported among cases exposed to mater-
nal docosahexaenoic acid [61] and low maternal retinol
during the second trimester [60]. SSD offspring were more
likely to be born to mothers with high pre-pregnancy body
mass index (BMI ≥30; [63, 64]) or elevated BMI during
pregnancy [51]. Decreased risk of SSD in male offspring
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ported intake) was also reported [62]; conversely, a sub-
sequent case-control study utilising bio-banked blood
samples demonstrated increased risk of SSD conferred
by both low and high neonatal vitamin D [68]. An in-
creased risk for AP in offspring exposed to maternal
smoking [67] contrasted with a lack of evidence for a
maternal smoking effect in SSD [38, 45]. The significant
effects observed for SSD and AP were typically small to
medium in magnitude.Obstetric complications
There is more extensive evidence concerning risk conferred
by obstetric complications for SSD than AP. Seven birth
cohorts [13, 38, 58, 63, 69–72], four population cohorts
[59, 73–75], two high-risk cohorts [42, 76], and ten case-
control cohorts [50–52, 77–83] provided data on SSD. Of
these, three birth cohorts [29, 58, 72], three population
cohorts [59, 73, 74], and two case-control cohorts [50, 54]
also provided data concerning effects on AP. An additional
case-control study provided data solely on AP [67].
Among those cohorts providing data for both outcomes,
increased risk for both disorders was associated with pre-
mature birth [59, 74] and bleeding during pregnancy [58]
(but see [50] indicating a significant effect for SSD only).
Risk factors with significant effects on SSD, but not AP,
included a high obstetric complications index score [13],
fewer than 10 antenatal visits [58], and hypoxia-related
complications [72]. Conversely, abnormal presentation of
the foetus [52, 54] and non-spontaneous delivery [58] were
associated with an increased risk for AP, but not SSD, as
was small for gestational age ([73]; but see [29] for evidence
that this factor also increases risk for SSD). All significant
effect sizes for these risk factors ranged from small to large.
While considerable evidence implicates obstetric com-
plications collectively as a risk factor contributing to both
SSD and AP, there is limited evidence for any individual
type of obstetric complication conferring risk for SSD or
AP. Nonetheless, the following specific abnormalities are
implicated in increasing risk for SSD (typically not yet
examined on an individual basis for AP): foetal growth
indicators (e.g., small for gestational age [29], small head
circumference [77], low and high birth weight [38, 70],
and short birth length [70]); potential hypoxia-related fac-
tors [29] (including low Apgar score [29, 38], placental
abnormality [42], placental abruption [38], umbilical cord
knotting [80], and atypical foetal presentation [80, 84]);
and obstetric complication composite scores [50, 82].
However, non-significant effects for many of these risk
factors were also reported for SSD [42, 63, 69, 78, 83, 84]
and AP [67]. Unusually, in one case-control cohort, sig-
nificant reductions in risk for SSD were associated with
exposure to abdominal/pelvic X-ray, pre-eclampsia andmaternal admission to hospital [52], but these effects were
not observed for AP [54].
Summary of conception, pregnancy, and birth risk factors
A greater quantity of research has been undertaken for
SSD than AP regarding the effects of exposure to concep-
tion, pregnancy, and birth factors, with the consequence
that much evidence implicates these factors in SSD. None-
theless, of all the risk factors summarised in Table 1 for
AP, the greatest amount of evidence also implicates these
factors. Effect sizes in most instances are small or medium
for both SSD and AP (although several large effects were
associated with some obstetric complications), and nega-
tive findings are almost as commonly observed as positive.
There is often a lack of replication for individual risk fac-
tors across studies (in some cases attributable to hetero-
geneity in the categorisation of continuous variables such
as birth weight and gestational age). The number of studies
presenting data on both SSD and AP is limited.
Demographic and familial risk factors (Table 1; Additional
file 2: Table S2)
Maternal age at birth
Estimates of the effect of maternal age at birth on risk
for SSD were available from one birth cohort [58], one
population cohort [59], one high-risk cohort [43], and
two case-control cohorts [45, 85]. The birth and popu-
lation cohorts [58, 59], and a case-control cohort [50]
also provided data for AP. Among studies showing a
significant effect are those demonstrating increased risk
for SSD in offspring whose mothers were younger at
birth (<30 years [85] and <19 years [59]), while an in-
consistent pattern of evidence relates to older mothers,
including both increased risk of SSD in offspring of
mothers ≥40 years in the population cohort [59], but
decreased risk in offspring of mothers >30 years in a
case-control cohort [85]. These effects are small to
medium in magnitude. Among the three studies also
reporting on AP, there is a lack of any effect of mater-
nal age, with the exception of the birth cohort that
showed a medium-sized increase in risk for mothers
aged >34 years [58]. Thus, for both disorders, the state
of evidence concerning this risk factor is inconclusive.
Paternal age at birth
Evidence concerning the effect of paternal age at birth on
risk of SSD among offspring was available as adjusted ef-
fect sizes reported from three birth cohorts [86–88], two
population cohorts [73, 89], and one case-control (sibling)
cohort [85]. The population and case-control cohorts also
provided data relating to AP, and one birth cohort pro-
vided data only for AP [90]. A more consistent pattern of
findings emerged regarding paternal age at birth relative
to that for maternal age, with increased risk for SSD
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34 years [89]. These effects were of small to medium mag-
nitude (the latter especially for the more advanced pater-
nal ages – see Additional file 2: Table S2), with large
effects for paternal age ≥35 years observed among off-
spring who also had family history of SSD [87]. Of the two
population cohorts providing evidence relating to AP, one
showed increased risk associated with older paternal age
(>30 years; small effect [73]), which was consistent with
evidence from the birth cohort (35–44 years [90]). Thus, a
pattern of increased risk for both SSD and AP appears to
be conferred by advanced paternal age at birth, with no
obvious effect relating to younger ages for either disorder.Parental education
Data on the effects of parental educational attainment on
SSD were available from one birth cohort [63, 91], one
population cohort [59], one high-risk cohort [43], and two
case-control cohorts [45, 49]. The population cohort pro-
vided concurrent data relating to AP, with information on
AP also available from an additional case-control cohort
[67]. With the exception of the birth cohort [91], the data
pertained only to maternal education. Evidence for small
and medium-sized effects of lower maternal education
levels on increased risk for SSD was identified in the popu-
lation cohort [59], the birth cohort [91] (although note the
lack of evidence within a subset of this cohort [63]), and
one of the case-control cohorts [45]. The birth cohort
demonstrated a similar effect for lower paternal educational
attainment [91]. In contrast, the high-risk cohort showed
evidence for a large effect of higher maternal education for
SSD, but this is in the context of a maternal history of
schizophrenia [43]. Neither the population [59] nor case-
control cohorts [67] reporting on AP found any effect for
maternal education. Thus, the evidence suggests a repli-
cated effect of lower maternal educational attainment on
SSD, with non-significant findings in relation to AP.Socio-economic status
Data regarding the effect of socio-economic status (SES;
usually indexed by paternal occupation) on risk for SSD
was provided by four birth cohorts [29, 91–95], one high-
risk cohort [65], and six case-control studies [51, 96–100].
No published studies on SES were available for AP. All
birth cohorts reported a significant effect for low SES
(family, paternal, maternal, or area SES indicator) on in-
creased risk of SSD. With the exception of one finding of
a large effect [29], these effects were of small magnitude
[91, 92, 95]. One birth cohort also identified a significant
increase, of medium magnitude, in risk of SSD among in-
dividuals with the highest SES [94]. No significant effects
were observed in the high-risk cohort, where only a small
sample was available. Among the case-control cohorts,only one reported a significant effect, of large magnitude,
for a low SES index (combining parental SES and area
SES indicators). Against these consistent results, a single,
case-control study indicated a small effect of decreased
risk of SSD for individuals of low SES relative to high [97].
Comparative data for AP are needed.Urbanicity
Effects of urbanicity on both SSD and AP were exam-
ined using data from two population cohorts [73, 101],
with additional data available for SSD only from one
high-risk cohort [66] and a case-control cohort [49]. All
except the high-risk cohort reported a significant in-
crease in risk for SSD, of small effect size, conferred by
urban birth. In contrast, the evidence available from the
population cohorts relating to AP was contradictory,
with Laursen et al. [73] demonstrating an elevated risk
for both SSD and AP conferred by urban birth, whereas
Marcelis et al. [101] reported a decreased risk for AP as-
sociated with urban birth. Arguably, more weight might
be assigned to findings of the first study, given its adjust-
ment for a more extensive range of potential confounds.
Nonetheless, further evidence relating to AP is needed
to draw definitive conclusions regarding the relative ef-
fects of urban birth on risk for SSD and AP.Migration and ethnicity
Prior meta-analyses support an effect of migrant/ethnic
status on risk for SSD (e.g., [102]). Here we sought pri-
mary data that permitted calculation of the effects of
migrant status on risk for SSD in studies where cases
and controls were defined on the basis of psychiatric
diagnosis. These data were available from one birth co-
hort [103], and two further birth cohorts [63, 104] also
provided such data, but with maternal ethnicity instead
of migrant status. Offspring with African-American
(relative to white American) mothers experienced in-
creased risk (medium-sized effect) for SSD in one birth
cohort [63], but not the other [104]. More weight might be
given to the latter finding due to its adjustment for poten-
tial confounds. Second-generation immigrant status was
also not observed to confer a significant increase in risk of
SSD [103]. For AP, data were provided by only one case-
control cohort [67]; in contrast with SSD, risk of AP in this
investigation was elevated among offspring of mothers with
Caucasian ethnicity (small effect) but not offspring of
African-American mothers or other maternal ethnicities.
Thus, while rates of SSD appear elevated among migrant
and ethnic minority groups when examined at a population
level using meta-analysis [102], too few investigations met
our study inclusion criteria to support any definitive con-
clusions concerning migrant and ethnic status on risk for
SSD and AP.
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Data regarding the effects of family factors on risk for SSD
were provided by one birth cohort [29] and three high-risk
cohorts [65, 105–108]. The birth cohort [29] also provided
concurrent data for AP. The birth cohort showed increased
risk (medium effect) for SSD, but not AP, conferred by
atypical mother-child interactions. Five studies, based on
the three high-risk cohorts, consistently demonstrated in-
creased risk for SSD in association with poor child-parent
relationships (including “unsatisfactory” or “poor” relation-
ships with a parent, family instability, paternal or maternal
conflict, communication deviance, and negative affective
style), with medium to large effect sizes [65, 105–107]. Fur-
ther evidence from a high-risk study also indicated that pa-
ternal (but not maternal) absence, or institutional care
during early childhood, increased risk for SSD (large effect)
[108]. Although strong and apparently robust, findings of
increased risk for SSD conferred by dysfunctional family
factors derive predominantly from high-risk cohorts, and
may have limited generalizability to the population. Fur-
ther studies of these factors in relation to AP are needed.Sibship
Data on the effects of sibship and birth order patterns
on SSD were available from one population cohort [109]
and four case-control cohorts [49–51, 85]. One of the
case-control cohorts also provided data regarding AP
[50]; for neither disorder was there evidence of an effect
of twin birth on risk, whereas in another case-control
cohort a decreased risk of SSD in twins was found [49].
Being first born [51, 85], having greater than three sib-
lings [85], and a short interval between births [109] were
each associated with small- or medium-sized increases
in risk for SSD.
Summary of demographic and familial risk factors
Almost all evidence pertaining to the effect of demo-
graphic risk factors was available only for SSD, and limita-
tions included sparse replication and diverse categorisation
of variables across studies. The most consistent evidence
suggested increased risk for SSD, and possibly AP, con-
ferred by greater paternal age at birth, and increased risk of
SSD among offspring who experienced poor parental rela-
tionships as children, although evidence for the latter drew
predominantly from high-risk cohorts. The need for further
investigation of the influence of demographic and familial
factors on risk for AP is striking.
Childhood and adolescent risk factors (Table 1; Additional
file 2: Table S3)
Childhood illness
Data regarding the effect of childhood illness on SSD
were provided by three birth cohorts [93, 110–112] andone population cohort [113], with two of the birth
cohorts also providing concurrent data relating to risk
for AP [111, 113]. Two of the birth cohorts provided evi-
dence of increased risk of SSD associated with central
nervous system infections ([112], medium effect; but see
lack of significant effects in [93, 110]), and meningitis
and tuberculosis ([111], a large effect); the latter effects
were also present for AP (similarly, of large magnitude).
Perinatal brain damage was associated with later SSD
[93], as was head injury experienced between the ages of
11–15 years [113], but there was no effect of head injury
in the comparative data relating to AP. Thus, relatively
limited evidence suggests childhood infections and brain
damage confer increased risk for SSD, with infections
also contributing to risk of AP.
Other physical risk factors
One birth cohort [63] and one high-risk cohort [114]
provided the only evidence available concerning the ef-
fect of physical growth factors during childhood on SSD.
No corresponding evidence was available for AP. Shorter
height during early childhood [114], and the combination
of a low ponderal index at birth with high BMI at age
7 years [63] was associated with an increased risk for SSD
(effects of medium and large magnitude, respectively).
Substance misuse
Two birth cohorts [115, 116] provide the only evidence
regarding the effects of substance misuse on risk for
SSD, with both reporting a significant association, of
medium effect, between cannabis use during early ado-
lescence and heightened risk for SSD. No comparative
evidence was available regarding effects of cannabis or
other substance misuse on risk for AP.
Summary of child and adolescent risk factors
Relatively limited evidence is available (particularly with
respect to AP) concerning child and adolescent risk
factors. Nonetheless, the effects of shorter height and
cannabis use during early adolescence on risk for SSD
were observed in data from at least two cohorts, and the
significant effects observed for childhood infectious ill-
nesses on risk for both SSD and AP reinforces the need
for further research comparing the effects of these fac-
tors on both disorders.
Childhood and adolescent antecedents (Table 2; Additional
file 2: Table S4)
Social, emotional, and behavioural functioning and
psychosis symptoms
Early childhood (0–5 years) Limited early childhood
evidence from three cohorts (two birth [116, 117], one
high-risk [118]) supports an effect of patterns of child-
hood psychological functioning on risk for SSD and AP.
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and childhood psychopathology in males (but not fe-
males, [116]), significantly increases risk for SSD, with
small and large effect sizes, respectively. A small high-
risk study [118] provided evidence for a large effect of
elevated scores on the ‘Attention Problems’, ‘Aggressive
Behaviour’, and ‘Anxious/Depressed’ subscales of the
Child Behavior Checklist [119] on risk for AP. Conclu-
sions regarding diagnostic specificity are limited because
no studies directly compared SSD and AP outcomes.
While the limited evidence to date suggests early child-
hood psychopathology may be implicated in both, further
studies utilising a variety of study designs are needed.
Middle childhood (6–12 years) Four birth cohort
studies [29, 117, 120–124], and three high-risk studies
[22, 23, 125, 126] provide evidence relating to the
effect of middle childhood psychopathology on risk for
SSD. Two of the birth cohorts [29, 120, 121, 124] pro-
vide concurrent information regarding AP as well as
SSD, and one high-risk cohort [127] examined AP
only. Evidence from the two birth cohorts examining
both diagnoses concurrently indicated that both SSD
and AP are preceded by social, emotional, and behav-
ioural problems, although there was variability in the
relative strength of the effect sizes observed across co-
horts, antecedent measurement, and age of antecedent
assessment. The effects observed for AP were less con-
sistent than for SSD [29, 120, 121]. One birth cohort dem-
onstrated evidence for medium/large effects of childhood
psychosis symptoms on risk for SSD [123, 124], but not
for AP [124]. These symptoms remained predictive for
SSD up to age 38 years [123]. Further evidence from
both birth cohort and high-risk studies examining only
SSD implicates deviant behaviour, social maladjustment,
emotional instability, thought disorder, and negative
symptoms in conferring risk for SSD [22, 23, 117,
122, 125], with most of these effects of medium or
large magnitude. From the high-risk cohort examining
AP only, evidence of childhood behavioural and atten-
tion problems was found among those who later de-
veloped AP compared with healthy controls [127].
Early adolescence (13–15 years) Evidence regarding the
impact of early adolescent psychopathology on risk for
SSD was provided by two birth cohorts [116, 128], one
population cohort [129], and three high-risk cohorts
[24, 65, 76, 130]. One of the birth cohorts additionally pro-
vided evidence regarding AP [29]; and further evidence relat-
ing to AP only was provided by one population cohort [131]
and one high-risk cohort [132]. Evidence from the birth co-
hort permitting comparison of both outcomes indicated that
increased risk for both SSD and AP was conferred by con-
duct/oppositional disorder and depression (medium/largeeffect sizes), while only increased SSD risk, not AP risk,
was conferred by anxiety and attention-deficit/hyperactivity
disorder (medium effect sizes) [128]. Within the high-risk
cohorts examining only SSD, behavioural adjustment prob-
lems (poor family functioning, peer relationships, and
school behaviour [130]) and deviant behaviour [24] in-
creased risk of SSD with large effects, and disruptive behav-
iour increased this risk but with a medium effect size [65].
This was consistent with evidence of a reduction in risk
for SSD conferred by the presence of behavioural com-
petency (in conduct, orderliness, and motivation) in the
population cohort [129], and a medium effect for self-
reported overall psychopathology (among males only)
in increasing SSD risk in another birth cohort [116].
The latter cohort further showed a medium-to-large ef-
fect of increased risk for SSD among male adolescents
reporting psychotic-like thought problems, and a high-
risk cohort provided evidence of small and medium
effects respectively of increased risk for SSD among ad-
olescents displaying paranoid and peculiar/eccentric
behaviour [76]. In relation to AP, a small increase in
risk was associated with depression in a high-risk co-
hort [132], with no increased risk associated with irrit-
ability in a small population cohort [131].
Summary of social, emotional, behavioural and
psychosis-related antecedents A relatively robust evi-
dence base indicates increased risk for SSD in children
presenting social, emotional, and behavioural problems
and psychosis-related symptoms in childhood or adoles-
cence. Less evidence is available regarding antecedents
of AP, with preliminary evidence implicating social, emo-
tional, and behavioural problems, but not psychosis-
related symptoms.
Cognitive functioning
Early childhood (0–5 years) Evidence available for this
developmental period is limited to data from a single
birth cohort [133] and relates to SSD only, indicating a
medium effect size for poor cognitive functioning as an
antecedent of SSD.
Middle childhood (6–12 years) Five birth [29, 122,
133–137], two population [138, 139], three high-risk
[23, 130, 140–142], and two nested case-control [96, 143]
cohorts provide data pertaining to cognitive functioning in
middle childhood as an antecedent of SSD. One of the birth
cohorts [29, 135], one population cohort [139], and a case-
control cohort [96] additionally provide data relating to AP,
while a high-risk cohort provided evidence relating to AP
only [140]. From the three cohorts providing both SSD and
AP outcome data, the birth cohort provided consistent evi-
dence (medium and large effects) of low IQ as an ante-
cedent of SSD [29, 135], and mixed evidence of low IQ as
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assessed at age 26 years [29], but no effect at age 32 years
[135]). Conversely, the latter study indicated a large effect
of high IQ as an antecedent of AP [135], although this
finding should be interpreted with caution due to the un-
adjusted effect sizes and small size of the mania case group.
The population cohort reported an inverse relationship
between IQ and risk of SSD and of AP, but this was not
significant for either disorder [139], whereas the nested
case-control cohort indicated medium to large effects for
lower IQ and several other cognitive impairments (par-
ticularly attention and working memory) as antecedents
of SSD and AP, usually of slightly greater magnitude for
SSD [96]. In the latter study, poorer academic achieve-
ment and perceptual motor ability showed medium ef-
fects as antecedents of SSD, but were not significantly
related to AP outcome. The high-risk cohort providing
evidence on AP only reported no significant effect of
lower IQ on AP risk [140].
Consistent with the conclusions published in recent
meta-analyses [11, 12, 144] implicating premorbid
intelligence deficits as an antecedent of SSD, robust evi-
dence of medium to large effects is available across birth,
high-risk, and case-control cohorts in support of this as-
sociation [29, 96, 133, 135–138, 141, 142]. Less data is
available relating to academic achievement or other
specific cognitive functions (e.g., attention, reading, vo-
cabulary, etc.) as antecedents of SSD, with small [138],
medium [96, 134], and large [96, 143], as well as non-
significant [23], effects reported; the balance of evidence
to date suggests a potentially broad range of premorbid
cognitive impairments as antecedents of SSD.Early adolescence (13–15 years) Two birth cohorts
[134, 145], two population cohorts [129, 146], and two
high-risk cohorts [65, 147] examined cognitive functioning
in early adolescence as an antecedent for SSD, with one
population cohort also providing the only data relating to
AP [146]. The latter study indicated no significant effect
for lower verbal, spatial, or inductive abilities for either
SSD or AP. For SSD, medium effects were observed for
low IQ [147] (but no effect in [65]), for verbal, non-verbal,
and arithmetic tests [134], and for below-age/special
schooling level [145] (but no effect for academic achieve-
ment in [129]). The non-standardised nature of school-
based cognitive measures may lack sensitivity to detect
effects, while being in a special school or class may index
marked impairments. The question of whether premorbid
cognitive impairments become less prominent in early
adolescence relative to those observed in middle child-
hood for SSD requires further longitudinal study, as does
the question of whether cognitive dysfunctions in early
adolescence constitute antecedents of AP.Summary of cognitive functioning antecedents There
is robust evidence implicating poor cognitive functioning
in middle childhood as an antecedent of SSD; sugges-
tions that these deficits might emerge in early childhood
and continue through early adolescence require further
examination. Considerably less evidence is available re-
garding cognitive dysfunctions as antecedents of AP,
with preliminary indications that both the low and high
ends of the functional distribution might be associated
with later AP.Language functioning
Early childhood (0–5 years) Evidence that develop-
mental language disorder in early childhood confers a
significantly increased risk for SSD (medium effect,
based on unadjusted effect sizes) was available from a
single population cohort [148], that reported no such
effect for AP (although the latter was tested using only a
small number of AP cases).Middle childhood (6–12 years) Data examining lan-
guage functioning in middle childhood as an antecedent of
SSD were provided by four birth cohorts [13, 111, 117, 134]
and a high-risk cohort [149], with two of the birth cohorts
also providing data regarding AP [13, 111]. Expressive
language deficits conferred a significant increase in risk
(medium effects) for both SSD and AP in one birth cohort
[13], while speech problems were antecedent only to SSD
and not AP in the other birth cohort [111]. Receptive lan-
guage deficits had significant effects for SSD only (consti-
tuting a large but unadjusted effect size based on data
spanning early-middle childhood years) [13]. Among the
investigations reporting only on SSD, a large effect (based
on adjusted effect sizes) was observed for abnormal speech,
and significantly poorer expressive language and word asso-
ciation performance in one birth cohort, but no significant
effects were reported for non-structural speech problems in
a birth cohort [111] or for verbal associative disturbances in
the high-risk cohort [149].Early adolescence (13–15 years) Our review identified
no cohorts providing data on language functioning in early
adolescence for either the SSD or AP outcomes.Summary of language antecedents Although several
studies report no significant findings, problems with lan-
guage expression appear to confer medium to large magni-
tude effect sizes for increased risk of both SSD and AP,
whereas receptive language deficits and speech problems
may be antecedent only to SSD. Further data relating to the
development of AP are needed.
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Early childhood (0–5 years) Data from three birth co-
horts [13, 150, 151] and a nested case-control study
[78] provided evidence relating to motor dysfunctions
or delayed motor milestone attainment during the
early childhood years as an antecedent of SSD, with
only one birth cohort providing concurrent data re-
garding AP [29]. In the latter, neurological abnormal-
ities were related to SSD (medium effect) but not AP.
A birth cohort and a case-control investigation exam-
ining SSD outcome only provided evidence of medium
to large effects for delayed attainment of motor mile-
stones (e.g., unsupported sitting, standing, and/or
walking [78, 150]), and another birth cohort reported
a medium effect for unusual movements/postural ab-
normalities [151].
Middle childhood (6–12 years) Four birth cohorts
[13, 111, 151, 152] and three high-risk cohorts
[23, 126, 153–157] provided data to examine motor
functioning in middle childhood as an antecedent for
SSD, with two of the birth cohorts additionally provid-
ing data for AP [13, 111]. These two cohorts suggest
that motor coordination and hand control problems
may index risk for SSD, but not AP, although these
medium-sized effects were estimated and unadjusted
for potential confounding factors. Conversely, poor
motor development and neurological problems con-
ferred a significant risk (large effect sizes) for both dis-
orders, with unsteadiness potentially also contributing
to both outcomes. From a birth cohort and a high-risk
cohort examining only SSD, significant increases in
risk, of medium effect sizes, were found among chil-
dren with minor physical anomalies [154], ocular
alignment abnormalities [155], several indices of poor
motor coordination [157], and unusual movements or
postural abnormalities [151]. However, other high-risk
cohorts demonstrate non-significant effects for neuro-
motor deficits as antecedent of SSD, including invol-
untary and abnormal movements [126], neurological
soft signs [23], and gross motor skills [153], while both
birth and high-risk cohorts show no significant associ-
ations between laterality (left- or mixed-hand prefer-
ence) with SSD [111, 152, 156].
Early adolescence (13–15 years) Our review identified
no cohorts providing data on motor functioning in early
adolescence for either SSD or AP.
Summary of motor antecedents Delays in early child-
hood milestone attainment, and poor motor develop-
ment and neurological problems in early and middle
childhood, confer increased risk for later SSD, with simi-
lar dysfunctions in middle childhood also evident inindividuals who later develop AP. Findings related to
other motor skills or neurological soft signs are equivo-
cal, and little evidence supports laterality disturbances in
middle childhood as antecedent of SSD. Limited data, of
large effect, suggests that poor motor development and
neurological problems may also precede AP.
Discussion
This systematic review aimed to elucidate common and
distinct risk factors and antecedents characterising the
developmental profiles of SSD and AP, which are groups
of disorders that share both phenotypic and genetic fea-
tures that suggest some overlap of aetiological mecha-
nisms. The available evidence indicates that individuals
who develop SSD experience diverse premorbid develop-
mental deficits and risk exposures, spanning the prenatal
period through early adolescence, although the effects
are typically subtle. There is relatively less evidence
supporting these risk exposures and patterns of pre-
morbid functioning in AP, largely reflecting limited
prospective investigation of this outcome. Few studies
are available that afford direct comparison between
the two groups of disorders within the same cohort.
Amongst these studies, an overall trend emerges for
larger effect sizes and a greater number of significant
associations for SSD than AP. While this suggests
some degree of specificity of many factors for SSD, a
lack of available prospective data examining AP limits
any conclusions regarding such specificity.
Risk factors and antecedents for SSD
Amongst the risk factors examined in relation to SSD,
the greatest amount of evidence was for obstetric com-
plications, maternal infections during pregnancy, and
other predominantly maternal physical factors, although
for each of these categories almost half of the investiga-
tions reported non-significant effects. The positive evi-
dence typically spanned the range of prospective study
designs considered, and effect sizes ranged in magnitude
from small to large. As the majority of effects were small
to medium, the predictive sensitivity of any of these indi-
vidual factors would be modest at best. All evidence re-
garding the influence of family factors on SSD was
positive, and of medium or large effect, but derived al-
most exclusively from high-risk cohorts, and might not
generalise to the population. For antecedents, the most
consistently positive findings observed were premorbid
deficits in cognitive functioning (particularly IQ) in the
middle childhood period, and social, emotional, and
behavioural problems, and psychosis symptoms in both
middle childhood and in early adolescence. Effect sizes
for these antecedents were predominantly of medium or
large magnitude. A number of birth cohort and high-
risk investigations also provided evidence of medium to
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childhood, although almost half of studies reported no
significant effects.
This review focuses on comparison of the risk factors
and antecedents implicated in SSD and AP, rather than a
detailed treatment of each specific factor and antecedent.
For SSD in particular, a number of quality systematic
reviews and meta-analyses are available for particular
factors. A freely-available online resource, the Schizophre-
nia Library ([158, 159]; http://www.schizophreniaresearch.
org.au/library/) collates the evidence from systematic re-
views and meta-analyses (including those dealing with risk
factors and antecedents of schizophrenia), grades the qual-
ity of the evidence available on each topic, and quantifies
the magnitude of observed effects as small, medium, or
large.
Risk factors and antecedents for AP
The majority of evidence pertains to SSD, with no stud-
ies investigating AP in relation to maternal psychological
factors during pregnancy, SES, childhood/adolescent
physical risk factors, substance misuse, early childhood
cognitive functioning, or early adolescent language and
motor functioning. Many other factor/antecedent cat-
egories had a single cohort contributing data and often
reported a non-significant effect. It is unclear whether
this sparse evidence is partly attributable to publication
bias, which would suggest negative findings for the ma-
jority of these factors in relation to AP. This possibility
cannot be confirmed without studies that provide data
for both SSD and AP. Among the relatively scant evi-
dence from prospective investigations of AP, the most
consistent and strongest evidence (mostly of medium to
large effect) implicated obstetric complications in the
development of these disorders, although some non-
significant effects were also observed. This evidence de-
rived from all study designs except high-risk cohorts.
For all other risk factors, evidence was too sparse to
draw definitive conclusions beyond the need for more
prospective studies of these factors. Similarly, evidence
relating to antecedents of AP was sparse, with the great-
est amount and strongest of the limited evidence avail-
able for premorbid deficits in cognitive functioning, and
in emotional and behavioural psychopathology in middle
childhood. Large effects were observed in both of the
birth cohorts providing data on motor dysfunctions in
middle childhood. Again, data from prospective investi-
gations of the many potential antecedents are needed
(Table 2).
Common or distinct pathways to SSD and AP?
Heterogeneity in the measurement of risk factors and
antecedents for SSD and AP was likely to have contrib-
uted to a lack of consistently positive findings at anindividual risk factor/antecedent level, but this might
also suggest that the risks conferred by these factors
are diagnostically non-specific in nature, or that exist-
ing literature does not provide sufficient direct compar-
isons of SSD and AP to distinguish their aetiological
pathways. It is also important to note that the majority
of effect sizes were estimated, with no adjusted effect
sizes available for risk associated with several factors.
For unadjusted data, reported effects may be attenuated
when potential confounding factors, such as SES, are
taken into account.
Similarly, for most antecedent categories, evidence
from early childhood and early adolescence was sparse,
particularly for language and motor functioning. While
the strength of evidence relating to premorbid cognitive
dysfunction was derived primarily from the middle
childhood period, difficulties with social, emotional,
and behavioural functioning spanned early childhood
through adolescence. This may reflect different tem-
poral trajectories for distinct antecedents, with specific
deficits more likely to emerge at certain developmental
stages; however, the paucity of longitudinal data on
many of these factors makes it difficult to determine
the extent to which age and/or developmental stage
may moderate these effects.
It is now almost three decades since the publications
from the original proponents of the neurodevelopmental
hypothesis of schizophrenia [160, 161]. Their proposal,
that a disruption of brain development during early life
underlies the later emergence of psychosis during later
adolescence or early adulthood, has become well estab-
lished in the field, although the specific aetiological
mechanisms operating in development of the illness re-
main to be determined. The neurodevelopmental origins
of AP are relatively less well established in the literature,
but in the context of the shared genetic vulnerability for
schizophrenia and bipolar disorder [1–5], and the poten-
tial similarities in their neuropathology [6, 7], this review
offers a timely indication of the need for further primary
studies in this area, particularly studies that directly
compare developmental risk factors and antecedents for
SSD and AP. Multiple factors and antecedents impli-
cated in SSD (and, to a lesser degree, AP) are identified
within the present review; the next challenge is to in-
tegrate these findings into aetiological models that
can stimulate the generation of new prevention and
intervention trials. For example, a recent model draws
together elements from the neurodevelopmental hy-
pothesis with other major aetiological theories, namely
dopamine and cognitive models of schizophrenia, to de-
scribe how early life events and the cognitions associated
with them may act on an underlying biological vulnerabil-
ity of dopamine dysregulation [162]. Accordingly, social
and psychological interventions that reduce stress and
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modifying the mechanisms that dysregulate dopamine
function. The present review identifies multiple factors
and antecedents that might usefully be integrated into
such models of illness aetiology to offer additional social,
psychological, and cognitive targets for prevention and
early intervention. Further, the review offers information
regarding the specific childhood periods (early vs. middle
childhood vs. early adolescence) in which such interven-
tions might be targeted, according to risks emerging in
these developmental periods.
Implications of prevalence rates for preventative
intervention
Substantial variation across studies was observed in the
prevalence of risk factors and antecedents, which likely
reflects differences in study design and measures used,
methods of case selection and definition, and sample
sizes. Prevalence rates drawn from population cohorts
are likely to better reflect the true distribution of risk
factors and antecedents in the population than those
drawn from case-control/high-risk cohorts, where sam-
pling bias may be operating. Greater confidence may be
invested where consistency in rates across designs is
observed.
Amongst factors for which consistent significant
effects were reported, the prevalence of such factors
may inform choice of approach for preventative inter-
ventions. Relatively high prevalence rates amongst
cases were generally associated also with high preva-
lence in control groups, suggesting potential relevance
for universal rather than targeted interventions. For
example, poor family relationships (communication
deviance, negative affective style, poor relationship
with parents) were reported for between 46-80 % of
SSD cases, compared with 16–29 % of healthy controls
[106, 107]; although note that these rates derived from
high-risk rather than birth/population cohorts. Pre-
morbid psychotic symptoms at age 11 years were
reported by almost half of those who later developed
SSD (48 % of cases) compared with 13 % of healthy
controls [124]. Other significant factors/antecedents of
SSD for which moderate prevalence rates were reported
included behavioural problems (31–38 % of cases versus 9–
19 % of healthy controls [24, 116, 117]), low IQ (16–43 %
of cases versus 3–26 % of healthy controls [133, 135, 137]),
and cannabis use during early adolescence (12–32 % of
cases versus 4–12 % of population controls [115, 116]). Less
common antecedents, which might merit targeted interven-
tions, include the Child Behavior Checklist-Bipolar Dis-
order phenotype as an antecedent to AP (present in 56 %
of cases compared with 5 % in those who developed other
disorders [118]), and motor coordination problems in rela-
tion to SSD (present in 11–14 % of those who developedSSD, compared with 3–4 % in healthy controls [111, 151]).
Considering that the majority of consistently reported
significant effects pertained to factors/antecedents that
were relatively common in the general population, the iden-
tification of risk profiles based on algorithms combining
multiple factors may increase predictive power for the pur-
poses of targeted interventions [163].
Limitations and future directions
This review had a broad remit, namely, to synthesise the
available evidence concerning the variety of develop-
mental risk factors and antecedents of SSD and AP ex-
amined to date that may be common or distinct to each
disorder group, so as to determine those with the most
robust support, and to highlight remaining evidence
gaps requiring further research. To achieve this, the lit-
erature search and reporting was limited in a number of
ways. These included the systematic search of only a sin-
gle database (Medline) and the restriction to full-text
publications written in English. We also restricted our
search to include only prospective studies, in an attempt
to mitigate against the potential bias of data obtained
using retrospective reports. Regarding reporting, we chose
to summarise the risk factors and antecedents, respect-
ively, that increased risk of SSD and AP only (see Tables 1
and 2). A few studies [49, 52, 59, 81, 97, 101] reported data
on various factors/antecedents for which a decreased risk
of either outcome was identified, but were too isolated to
permit any definitive conclusions regarding a potential
protective effect conferred by such factors; these factors
were therefore not incorporated in the Tables 1 and 2 sum-
maries, but are noted in the text and Supplementary
Tables. The mixed reporting of unadjusted and adjusted
effect sizes was also necessary because the data from
some studies permitted only the estimation of un-
adjusted effect sizes. Adjusted effect sizes are typic-
ally more useful; however, even amongst the adjusted
effect sizes, inconsistencies arose due to the variabil-
ity in confounders adjusted for. Moreover, depending
on the confounders included in the model, adequate
adjustment is not necessarily achieved. Given these
issues, future reviews focused specifically on a particular
factor or antecedent may overcome some of these limi-
tations, and could incorporate retrospective studies to
examine consistency of findings across the prospective
and retrospective designs. Those reviews might delineate
both risk and protective factors that may be operating at
certain stages of development.
More permissive future reviews might also be able to
examine a number of methodological factors that may
contribute to heterogeneity of study findings but for which
insufficient primary studies were available for consider-
ation in the present review. Examples include diagnostic
definitions employed (e.g., International Classification of
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of Mental Disorders [DSM] criteria; Kraepelinian versus
non-Kraepelinian courses of disease progression), sex dif-
ferences, and age of onset of disorder. Here, the classifica-
tion of disorders as SSD and AP was made according to
their original designation in the included primary study.
Search criteria were inclusive of all diagnoses in the SSD
and AP groups, without specification of ICD or DSM cri-
teria, which vary in detail such as the duration of symp-
toms required. Any diagnostic instability not accounted
for in the original publications (e.g., where a non-affective
first-episode psychosis presentation later evolves to AP)
would likely bias the review toward identifying risk factors
and antecedents that were common, rather than unique,
to SSD and AP.
With respect to the translation of these epidemiological
findings to new clinical or prevention recommendations, it
is important to note that any evidence summarised here
might be biased by residual confounding, as is inherent to
observational studies. The covariates considered in each
study are summarised in Additional file 3: Table S5, with
variability apparent across studies. Although a number of
investigations included parental history of psychoses as a
covariate in their analyses, few investigations reported data
indicating the effect of family history of psychoses. For in-
stance, the birth cohort investigations reporting on de-
pressed mood in pregnancy [33] and paternal age [87],
respectively, indicated higher risk of SSD among individuals
with a positive family history. Where findings from high-
risk cohorts diverge from those obtained in birth or popula-
tion cohort studies, this might suggest a potential effect of
family history. Further primary studies that report these
data are needed to examine how family history of SSD and/
or AP may impact the findings and translational utility.
Finally, the capacity to identify common or distinct risk
factors and antecedents operating in the aetiological path-
ways to SSD or AP within the current literature is limited
not only by scant availability of prospective data for AP,
but also by inconsistency in the effects observed. This is
likely primarily due to differences in methodologies.
Firstly, measures and thresholds used to define risk factors
and antecedents differ greatly between studies. This is
especially the case for exposures that are continuous in
nature, where the change in risk associated with increas-
ing exposure is unclear. Secondly, there is considerable
variability in the sample sizes used across studies, espe-
cially for case groups where smaller numbers are likely
underpowered to detect effects. This is especially pertin-
ent within the limited literature relating to AP, which may
bias findings regarding disorder specificity. Thirdly, incon-
sistencies or inadequacies of case definition may contrib-
ute to the dilution of observed effects, particularly for AP
cases where many studies have not confirmed the pres-
ence of psychosis. Lastly, variability in age of assessmentacross studies makes informative comparisons difficult
and limits the ability to investigate the effect of age/devel-
opmental stage as a moderator of observed effects. Most
studies have used either data pooled across different age
groups/stages at assessment, or have measured particular
factors at one time point only, thus restricting the ability
to ascertain developmental effects. Moreover, samples
encompassing a broad age range at assessment may not
well characterise the typical developmental profile during
that period.Conclusions
This review highlights a striking gap in the literature
regarding risk factors and antecedents for AP, and also
highlights risk factors/antecedents of SSD that would bene-
fit from further investigation. Whilst several risks associated
with SSD are identified, it remains unclear whether these
also characterise AP or are SSD-specific. Further, reliable
comparisons from the evidence regarding specificity are
hampered by lack of replication. Many of the factors inves-
tigated have previously been shown to increase risk for
multiple disorders (e.g., [128, 164]), but AP is not often
among those reported. This constitutes a significant limita-
tion in the current evidence base in light of data from gen-
etic studies underlining potential similarities in the
aetiology of SSD and AP. Future research requires the
investigation of AP and SSD concurrently to establish
whether these similarities extend to common aetiological
pathways for some individuals with these diagnoses. The
low prevalence of both disorders calls for population-based
approaches to provide the necessary power to detect effects,
as well as to capture the full spectrum of premorbid expo-
sures and developmental deviations that may characterise
those who later develop either disorder. From an interven-
tion perspective, applying a longitudinal framework to these
investigations will further enhance scope to determine how
early developmental deviations may be detected, or at
which point during development they are most sensitive for
indicating risk for later SSD or AP.Additional files
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